The first report of two cases of fatal liver injury due to anti-tuberculosis drugs in the presence of alpha-1 antitrypsin deficiency
Tuberculosis (TB) is a major global health problem. Awareness of liver injury due to anti-TB therapy is vital because fulminant hepatic failure is a devastating and often fatal condition without liver transplantation. Here, we report for the first time, two patients of fatal liver injury due to anti...
Main Authors: | Shahram Habibzadeh, Jafar Mohammad Shahi, Hassan Ghobadi, Nasrollah Maleki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=187;epage=190;aulast=Habibzadeh |
Similar Items
-
Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
by: Belchamber KBR, et al.
Published: (2020-12-01) -
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
by: Francesco Callea, et al.
Published: (2018-05-01) -
Identification of bioactive molecules for the treatment of alpha₁-antitrypsin deficiency
by: Ekeowa, Ugochukwu Ifedi
Published: (2012) -
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years
by: Mostafavi B, et al.
Published: (2019-02-01) -
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)